000259995 000__ 01300pam\a22003254a\4500
000259995 001__ 259995
000259995 005__ 20210513100559.0
000259995 008__ 001208s2001\\\\nyua\\\\\b\\\\001\0\eng\\
000259995 010__ $$a   00068834
000259995 020__ $$a078901307X (pbk. : alk. paper)
000259995 020__ $$a0789013061 (alk. paper)
000259995 035__ $$a(OCoLC)ocm45582530
000259995 035__ $$a259995
000259995 040__ $$aDLC$$cDLC
000259995 042__ $$apcc
000259995 043__ $$an-us---
000259995 049__ $$aISEA
000259995 05000 $$aRA412.3$$b.P73 2001
000259995 08200 $$a362.1/782/0973$$221
000259995 24500 $$aPrescription drugs under medicare :$$bthe legacy of the Task Force on Prescription Drugs /$$cMickey C. Smith, editor.
000259995 260__ $$aNew York :$$bPharmaceutical Products Press,$$cc2001.
000259995 300__ $$a277 p. :$$bill. ;$$c22 cm.
000259995 500__ $$a"Prescription drugs under medicare: the legacy of the Task Force on Prescription Drugs has been co-published simultaneously as Journal of research in pharmaceutical economics, Volume 10, Numbers 2/3 and 4 2001."
000259995 504__ $$aIncludes bibliographical references and index.
000259995 650_0 $$aMedicare.
000259995 650_0 $$aPrescription pricing$$zUnited States.
000259995 650_0 $$aPharmaceutical services insurance$$zUnited States.
000259995 7001_ $$aSmith, Mickey C.
000259995 7101_ $$aUnited States.$$bTask Force on Prescription Drugs.
000259995 7300_ $$aJournal of research in pharmaceutical economics.
000259995 85200 $$bgen$$hRA412.3$$i.P73$$i2001
000259995 909CO $$ooai:library.usi.edu:259995$$pGLOBAL_SET
000259995 980__ $$aBIB
000259995 980__ $$aBOOK